Qatar's health expenditure to surge 14% by 2029
DOHA: Qatar's healthcare industry is poised for rapid expansion, with total health spending projected to grow at a compound annual growth rate (CAGR) of 14 percent by 2029, reaching $11.5bn (QR42bn), according to a recent report by Fitch Solutions.
Health experts note that this growth would make Qatar the third-largest healthcare market in the Gulf Cooperation Council (GCC) and the tenth-largest in the Middle East and North Africa (MENA) region.
Despite these impressive figures, analysts at Fitch Solutions stress that Qatar's overall market opportunities are challenging compared to other regional players. This is primarily due to the country's small population size and modest short-term economic growth prospects.
'The numbers show a healthy trajectory, but we must be careful not to confuse high growth rates with large-scale opportunity,' said Dr. Lisa Kurian, a Doha-based public health specialist. 'Qatar's small population means we are working with a narrower base, even if spending per capita is among the highest in the
region.'
Government investment, driven by the National Development Strategy 2024–2030, continues to underpin the growth in public health expenditure. Meanwhile, the private sector is benefiting from strong per capita health spending and ongoing public-private partnerships.
'Qatar has done well to encourage private sector involvement without compromising public oversight,' said Dr. Kurian adding that projects like Surgi Art Hospital are proof that collaboration is driving innovation in patient care.
On the other hand, digital transformation is also playing a key role in ensuring efficient healthcare delivery. Government-backed initiatives like the Smart Programme (TASMU) aim to leverage big data, AI, and integrated electronic health records to streamline services and prevent resource bottlenecks.
In July 2024, the government signed an agreement with AI firm Lunit to introduce AI-powered breast cancer screening tools across primary health centres—an initiative expected to enhance early detection and reduce long-term costs.
'Investing in AI for diagnostics is not just about innovation—it's about sustainability. Early diagnosis means better outcomes and lower treatment costs, which is critical for long-term health system viability, the medical expert said.
She also emphasised that 'Technology cannot replace people. Without well-trained, adequately supported staff, even the most advanced tools will fall short of their potential.'
As Qatar positions itself as a leader in high-value healthcare within the region, striking the right balance between innovation, infrastructure, and human capital will be critical.
Additionally, researchers highlight that the next phase of development must focus on systemic resilience, ensuring that digital health tools, regulatory frameworks, and a capable workforce work together cohesively to deliver quality care for a changing population.
With its strong fiscal position, high per capita income, and strategic vision for healthcare advancement, Qatar is also becoming an increasingly attractive destination for international healthcare companies, investors, and research institutions.
© Dar Al Sharq Press, Printing and Distribution. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
16 hours ago
- The National
A cancer crisis is inevitable. What can we do about it?
The number of cancer patients is set to rise dramatically throughout the entire Gulf region. This is simply because of changes in the age of its population. Cancer can, of course, occur at any age but it predominantly occurs in older people. In the UK, 25 per cent of the population is now over 60 compared to only 3.6 per cent in the UAE. The number of new cancer patients in this region per million people is currently less than half that in Europe. But this is set to change rapidly with a much more European age pattern coming to all GCC countries. The risk factors for cancer due to age are already locked-in, so a health crisis is inevitable. There will be a significant rise in both incidence (the number of new cases) and prevalence (the number of patients living with cancer). The World Health Organisation predicts a more than doubling of both in the GCC region by 2050. The 'big four' cancers are those arising in breast, colon, lung and prostate, which make up 65 per cent of diagnoses. Each cancer has its own age profile and causation. As breast cancer starts rising in women in their forties, it is unsurprising that we are already seeing a huge increase. The other types will surely follow in the next decade. But a real puzzle is emerging. Over the past 20 years, we have seen a dramatic increase of certain cancers in the 30-50 age group globally. This trend started in the 1990s, so has nothing to do with Covid-19 or its vaccines. Lymphoma, melanoma, head and neck as well as the big four cancers are all involved. What is going on and what can we do about it? We know that age is the biggest risk factor and we just cannot stop the clock. But changing lifestyles are definitely involved too. The interplay of diet, exercise and obesity can alter the hormonal balance in the body. How we work, play and relax now is different from the past. Only three generations ago, the Gulf was a land of nomadic tribesmen with a healthy lifestyle. Subsequent generations now sit in smart high-rise offices, often with sedentary lifestyles and a diet heavy with processed food. But why is this increasing the risk of cancer? Our lifestyle contributes to the composition of the microbiome – the bugs that colonise our intestines breaking down potential carcinogens and toxins. Powerful data-mining artificial intelligence programmes are being used to study the huge number of variables involved. Within five years, it is likely we will understand more clearly the factors causing defects in cell growth control that allow rogue cells to emerge. These become the enemy within – the cancer. Greater understanding will allow specific tailored cancer prevention advice to individuals. Prevention and screening messages are always far more powerful if individualised. Risk-based screening for common cancers will be revolutionised by multi-cancer early detection tests, or MCEDs. These pick up abnormal DNA fragments released by tiny early cancers which circulate in the blood. Although there are several on the market, they produce too high a false positive rate to be used on everyone. They can make the worried well even more worried. Eventually, a reliable, self-administered finger prick sample will be enough to diagnose cancer accurately, but we're just not there yet. Understanding the reasons that cancer arises at a molecular level will lead to both better prevention and more effective treatment strategies. But oncologists need to steer a delicate path between hope, hype and reality for this increasingly common disease Technology will allow us to diagnose cancer in its very early stages where outcomes are best. The Gulf is well provided with increasingly sensitive diagnostic scanners, both MRI and CT. And molecular analysis of biopsies from cancers will provide far more personalised individual drug and radiation combinations. The future physicians' laptop will not only choose the optimal therapy but also predict probable unpleasant side effects. AI will be used extensively to understand individual interactions to treatments – both good and bad allowing perfect personalisation. The Gulf has many excellent cancer treatment facilities. But there are few effective networks allowing the combination of international expertise bringing multi-disciplinary opinions for patients and yet delivering care close to their homes currently in place. Treating cancer effectively is no quick fix, often taking several months of frequent hospital visits for radiotherapy and chemotherapy. The medical tourism model used for elective surgery is not feasible. The increasing cost of optimal cancer care is driving government health bodies globally to reduce the wide inconsistencies in treatment protocols. Networked care from a mixed economy of public and private providers is very much the future. It allows the development of a financially sustainable model adapted to a country's overall wealth. Increasing financial investment into an individuals' cancer care obviously increases the benefit to the patient. But there is a limit – a therapeutic plateau – where further spending brings no benefit for the patient. Poorer countries such as those of middle Africa operate well below it; most of Europe and Asia is comfortably at its beginning but the US is far along it, spending vast sums of money for no gain in the last few months of a patients' life. Networked care is the solution to providing the best individual treatment and yet minimising its toxicity both for the patient and financially for the payor. Coupling the intellectual power of a large central university hospital with skilled technical care close to home is what families want. Currently we cure over 90 per cent of patients with early-stage cancer. When the disease has spread outside its organ of origin, this figure drops dramatically. So, the emphasis has to be on streamlining the diagnostic phase and fast-tracking treatment. The current emphasis is very much on maintaining the best quality of life both during and after therapy. We are now far more honest with our patients and try to manage their expectations with frankness. Breakthroughs appear in the media regularly driven by commercial interests from biotech and pharma companies and their investors. Their hyped-up message can often raise false hope. Public education and better screening lead to earlier diagnosis and better outcomes. Understanding the reasons that cancer arises at a molecular level will lead to both better prevention and more effective treatment strategies. But oncologists need to steer a delicate path between hope, hype and reality for this increasingly common disease.
Zawya
a day ago
- Zawya
Qatar's health expenditure to surge 14% by 2029
DOHA: Qatar's healthcare industry is poised for rapid expansion, with total health spending projected to grow at a compound annual growth rate (CAGR) of 14 percent by 2029, reaching $11.5bn (QR42bn), according to a recent report by Fitch Solutions. Health experts note that this growth would make Qatar the third-largest healthcare market in the Gulf Cooperation Council (GCC) and the tenth-largest in the Middle East and North Africa (MENA) region. Despite these impressive figures, analysts at Fitch Solutions stress that Qatar's overall market opportunities are challenging compared to other regional players. This is primarily due to the country's small population size and modest short-term economic growth prospects. 'The numbers show a healthy trajectory, but we must be careful not to confuse high growth rates with large-scale opportunity,' said Dr. Lisa Kurian, a Doha-based public health specialist. 'Qatar's small population means we are working with a narrower base, even if spending per capita is among the highest in the region.' Government investment, driven by the National Development Strategy 2024–2030, continues to underpin the growth in public health expenditure. Meanwhile, the private sector is benefiting from strong per capita health spending and ongoing public-private partnerships. 'Qatar has done well to encourage private sector involvement without compromising public oversight,' said Dr. Kurian adding that projects like Surgi Art Hospital are proof that collaboration is driving innovation in patient care. On the other hand, digital transformation is also playing a key role in ensuring efficient healthcare delivery. Government-backed initiatives like the Smart Programme (TASMU) aim to leverage big data, AI, and integrated electronic health records to streamline services and prevent resource bottlenecks. In July 2024, the government signed an agreement with AI firm Lunit to introduce AI-powered breast cancer screening tools across primary health centres—an initiative expected to enhance early detection and reduce long-term costs. 'Investing in AI for diagnostics is not just about innovation—it's about sustainability. Early diagnosis means better outcomes and lower treatment costs, which is critical for long-term health system viability, the medical expert said. She also emphasised that 'Technology cannot replace people. Without well-trained, adequately supported staff, even the most advanced tools will fall short of their potential.' As Qatar positions itself as a leader in high-value healthcare within the region, striking the right balance between innovation, infrastructure, and human capital will be critical. Additionally, researchers highlight that the next phase of development must focus on systemic resilience, ensuring that digital health tools, regulatory frameworks, and a capable workforce work together cohesively to deliver quality care for a changing population. With its strong fiscal position, high per capita income, and strategic vision for healthcare advancement, Qatar is also becoming an increasingly attractive destination for international healthcare companies, investors, and research institutions. © Dar Al Sharq Press, Printing and Distribution. All Rights Reserved. Provided by SyndiGate Media Inc. (
Zawya
a day ago
- Zawya
World Bank Approves Health Resilience Project to Protect Lives and Strengthen Emergency Response in Mozambique
The World Bank has approved the Mozambique Health Emergency Preparedness, Response and Resilience Project, an initiative to strengthen the health system's ability to deliver essential services consistently and equitably. The project targets underserved and climate-vulnerable areas by investing in human resources, infrastructure, and systems that ensure continuity of care during emergencies. This project is part of a regional p rogram to strengthen health security across Eastern and Southern Africa. Mozambique faces frequent floods, cyclones, disease outbreaks, and other emergencies that disrupt health services and put lives at risk. Many communities lack sufficient and trained health workers, access to essential medicines, and the tools to detect and respond quickly to crises. The project seeks to address these gaps by: Strengthening the health workforce capacity, particularly in high-risk areas, by improving recruitment, training, and retention systems; Improving pharmaceutical supply chains by supporting the regulatory agency in bringing more transparency and speed to procurement processes, lowering and standardizing prices of health commodities to ensure access to medicines, particularly during crises; and Enhancing disease surveillance and laboratory capacity to improve early warning and response systems to quickly detect and respond to health emergencies like cholera outbreaks or heatwaves. The project also supports the development of climate-adaptive infrastructure and emergency preparedness plans, recognizing the growing health risks posed by climate change. ' Mozambique is already experiencing the health impacts of shocks and emergencies,' noted Luc Lecuit, World Bank Acting Division Director in Mozambique. 'The program supports the government's efforts to strengthen core health service delivery by investing in preparedness and resilience, ensuring services remain operational during floods, storms, and epidemics.' Financed through a $201 million grant from the International Development Association (IDA)*, the initiative will be implemented over five years, concluding in September 2030. 'By prioritizing practical investments in the foundational pillars of the health sector, the Government of Mozambique is driving greater efficiency across the system and strengthening its emergency response capacity to protect lives,' said João Pires, World Bank Senior Health Specialist and Task Team Leader. 'These efforts are paving the way for bold reforms to ensure the health system remains resilient and responsive, even under pressure.' In parallel, the World Bank, together with other development partners, is increasing its support to the Mozambique health sector through a $63.7 million top-up to the ongoing District and Community Health Services Revitalization Project. This additional financing—comprising $8.7 million from IDA, $5 million from the Global Financing Facility, and $50 million from a multi-donor trust fund supported by Canada, the United Kingdom, and Ireland—will expand the project's impact across the most vulnerable 63 districts of Mozambique. The operation focuses on improving access to quality primary health care, particularly for women, children, and adolescents, and strengthening service delivery at the district and community levels. Both projects align with the forthcoming Mozambique's Health Sector Strategic Plan (PESS, 2025-2034) (PESS 2020–2024) and the National Adaptation Plan (2023), and complement regional efforts to strengthen health security across Eastern and Southern Africa. Distributed by APO Group on behalf of The World Bank Group.
